Skip to main content
Have a personal or library account? Click to login
Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities Cover

Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities

Acta Pharmaceutica
Volume 63 (2013): Issue 2 (June 2013)
By: ,  ,  ,  ,   and    
Open Access
|Jul 2013
References

References

  1. 1. A. M. Siouffi and R. Phan-Tan-Luu, Optimization methods in chromatography and capillary electrophoresis,(2000) 75-106; DOI: 10.1016/S0021-9673(00)00247-8.
    Open DOISearch in Google Scholar
  2. 2. A. Malenović, Y. Dotsikas, M. Mašković, B. Jančić Stojanović, D. Ivanović and M. Medenica, Desirability-based optimization and its sensitivity analysis for the perindopril and its impurities analysis in a microemulsion LC system,.(2011) 454-460; DOI: 10.1016/j.microc. 2011.06.022.
    Search in Google Scholar
  3. 3. M. A. Bezerra, R. E. Santelli, E. P. Oliveira, L. S. Villar and L. A. Escaleira, Response surface methodology (RSM) as a tool for optimization in analytical chemistry,(2008) 965-977; DOI: 10.1016/j.talanta.2008.05.019.
    Open DOISearch in Google Scholar
  4. 4. S. L. C. Ferreira, W. N. L. Dos Santos, C. M. Quintella, B. B. Neto and J. M. Bosque-Sendra, Doehlert matrix: A chemometric tool for analytical chemistry-Review,(2004) 1061-1067; DOI: 10.1016/j.talanta.2004.01.015.
    Open DOISearch in Google Scholar
  5. 5. Y. Vander Heyden and D. L. Massart,, in(Eds. M. W. B. Hendriks, J. H. De Boer and A. K. Smilde), Elsevier, Amsterdam 1996.
    Open DOISearch in Google Scholar
  6. 6. Y. VanderHeyden, A. Nijhuis, J. Smeyers-Verbeke, B. G. M. Vandeginste and D. L. Massart, Guidance for robustness/ruggedness tests in method validation,(2001) 723-753; DOI: 10.1016/S0731-7085(00)00529-X.
    Open DOISearch in Google Scholar
  7. 7. M. Mašković, B. Jančić-Stojanović, A. Malenović, D. Ivanović and M. Medenica, Assessment of liquid chromatographic method robustness by use of Plackett-Burman design,.(2010) 281-296; DOI: 10.1556/AChrom.22.2010.2.10.
    Open DOISearch in Google Scholar
  8. 8. T. Rakić, A. Malenović, B. Jančić-Stojanović, D. Ivanović and M. Medenica, Avoiding the false negative results in LC method robustness testing by modifications of the algorithm of Dong and dummy factor effects approach,(2012) 397-401; DOI: 10.1007/s10337-012-2196-6.
    Open DOISearch in Google Scholar
  9. 9, 7th ed., Council of Europe, Strasbourg 2011, pp. 2297-2299.
    Search in Google Scholar
  10. 10. M. Dumarey, R. Sneyers, W. Janssens, I. Somers and Y. Vander Heyden, Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase(2009) 85-92; DOI: 10.1016/j.aca.2009.10.013.
    Open DOISearch in Google Scholar
  11. 11. D. Compas, D. J. Touw and P. N. F. C. de Goede, Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography,(1996) 453-456; DOI: 10.1016/S0378-4347(96)00245-9.
    Open DOISearch in Google Scholar
  12. 12. C. H. W. Koks, R. W. Sparidans, G. Lucassen, K. M. L. Crommentuyn and J. H. Beijnen, Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients(2002) 103-110; DOI: 10.1016/S0378-4347(01)00550-3.
    Open DOISearch in Google Scholar
  13. 13. V. Srivatsan, A. K. Dasgupta, P. Kale, R. R. Datla, D. Soni, M. Patel, R. Patel and C. Mavadhiya, Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high- -performance liquid chromatography,(2004) 307-313; DOI: 10.1016/j.chroma. 2003.11.061.
    Search in Google Scholar
  14. 14. T. Uno, M. Shimizu, K. Sugawara and T. Tateishi, Sensitive determination of itraconazole and its active metabolite in human plasma by column-switching high-performance liquid chromatography with ultraviolet detection,(2006) 526-531; DOI: 10.1097/00007691-200608000-00007.
    Open DOISearch in Google Scholar
  15. 15. P. Kubalec and E. Brandšteterová, Column-switching chromatographic determination of itraconazole and its metabolite hydroxy-itraconazole in human serum,(2001) 397-400.
    Search in Google Scholar
  16. 16. W. C. Young, D. Nam, H. K. Kyoung, W. H. Kyung, H. H. In, K. C. Byung, M. Yoon and J. Lee, High-performance liquid chromatographic-tandem mass spectrometric determination of itraconazole in human plasma for bioavailability and bioequivalence studies,(2006) 291-294; DOI: 10.5012/bkcs.2006.27.2.291.
    Open DOISearch in Google Scholar
  17. 17. L. Bai, M. M. Li, C. J. Zhao and T. T. Ma, Determination of itraconazole in human plasma by HPLC and studies of bioequivalence(2008) 1272-1274.
    Search in Google Scholar
  18. 18. J.W.Wong, U. R. Nisar and K. H. Yuen, Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies,(2003) 355-360; DOI: 10.1016/j.jchromb.2003.09.059.
    Open DOISearch in Google Scholar
  19. 19. L. Baietto, A. D’Avolio, G. Ventimiglia, F. G. De Rosa, M. Siccardi, M. Simiele, M. Sciandra and G. Di Perri, Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma,(2010) 3408-3413; DOI: 10.1128/AAC.01807-09.
    Open DOISearch in Google Scholar
  20. 20. W. Chen, B. Gu, H. Wang, J. Pan,W. Lu and H. Hou. Development and evaluation of novel itraconazole- loaded intravenous nanoparticles,.(2008) 133-140; DOI: 10.1016/j.ijpharm. 2008.05.039.
    Search in Google Scholar
  21. 21. L. Gagliardi, D. De Orsi, P. Chimenti, R. Porra and D. Tonelli, HPLC determiantion of imidazole antimycotics in antidandruff cosmetic products,(2003) 11951197; DOI: 10.2116/analsci. 19.1195.
    Search in Google Scholar
  22. 22. S. L. C. Ferreira, R. E. Bruns, E. G. P. da Silva, W. N. L. dos Santos, C. M. Quintella, J. M. Davis, J. B. de Andrade, M. C. Breitkreitz, I. C. S. F. Jardim and B. B. Neto, Statistical designs and response surface techniques for the optimization of chromatographic systems(2007) 2-14; DOI: 10.1016/j.chroma.2007.03.051.
    Open DOISearch in Google Scholar
  23. 23. R. L. Mason, R. F. Gunst and J. L. Hess,, 2nd ed., Hoboken, New York 2003.
    Open DOISearch in Google Scholar
  24. 24. G. C. Carle, Determination of chromatographic resolution for peaks of vast concentration differences,(1972) 1905-1906.
    Open DOISearch in Google Scholar
  25. 25. R. E. Kaiser,, Portig, Leipzig 1960, p. 33.
    Open DOISearch in Google Scholar
  26. 26. F. Dong, On the identification of active contrasts in unreplicated fractional factorials,(1993) 209-217.
    Search in Google Scholar
  27. 27. J. B. Crowther,, in(Eds. S. Ahuja and S. Scypinski), Academic Press, New York 2001, pp. 415-443.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/acph-2013-0015 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 159 - 173
Published on: Jul 10, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
itraconazole,
itraconazole impurities,
high performance liquid chromatography,
Box-Behnken design,
fractional factorial design
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Irena Kasagić, Anđelija Malenović, Marko Jovanović, Tijana Rakić, Biljana Jančić Stojanović, Darko Ivanović, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 63 (2013): Issue 2 (June 2013)
Previous article
Next article